Document Detail


Aliskiren Reduces Morning Blood Pressure in Hypertensive Patients with Diabetic Nephropathy on Hemodialysis.
MedLine Citation:
PMID:  23534458     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Our previous study indicated that the exchange from an angiotensin receptor blocker (ARB) to aliskiren reduced morning blood pressure and albuminuria in hypertensive patients with diabetic nephropathy. We extended the above study and assessed the effects of exchanging from an ARB to aliskiren on home blood pressure in hypertensive patients with diabetic nephropathy on chronic hemodialysis. The patients who were persistently hypertensive despite antihypertensive therapy, including ARB, were considered as candidates for the exchange from the ARB to aliskiren. Patients' age and durations of diabetes and hemodialysis were averaged as 62 ± 9 years old, 15 ± 8 and 7 ± 3 years, respectively. Aliskiren decreased morning systolic blood pressure (149 ± 14 to 144 ± 13 mm Hg, n = 30, P < .01) and plasma renin activity (3.5 ± 1.1 to 1.2 ± 0.6 ng/mL/h, P < .01) without changes in serum potassium. Aliskiren also reduced interdialytic weight gain (2.7 ± 0.6 to 2.5 ± 0.5 kg/interval, P < .05) and attenuated the magnitude of intradialytic declines in systolic (-20 ± 11 to -17 ± 10 mm Hg, P < .05) and diastolic blood pressure (-9 ± 6 to -5 ± 5 mm Hg, P < .01). The exchange from an ARB to aliskiren is safe and useful to control home blood pressure in hypertensive hemodialysis patients with diabetic nephropathy. Aliskiren reduced both intradialytic blood pressure drops and interdialytic weight gain in patients with DN.
Authors:
Tsuneo Takenaka; Mika Okayama; Eriko Kojima; Yuka Nodaira; Jonde Arai; Kosuke Uchida; Tomohiro Kikuta; Keita Sueyoshi; Hitoshi Hoshi; Yusuke Watanabe; Hiroshi Takane; Hiromichi Suzuki
Related Documents :
24678938 - Renal denervation for resistant hypertension?
12452528 - Clinical phenotyping strategies in selection of tobacco smokers for future genotyping s...
24905308 - Renoprotective activity of aliskiren, a renin inhibitor in cyclosporine a induced hyper...
7357968 - The effects of acute ethanol ingestion on pulmonary diffusing capacity.
9377138 - Feasibility of using finger arterial pressure in neonates.
11409708 - Blood pressure response to angiotensin ii, low-density lipoprotein cholesterol and poly...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-3-27
Journal Detail:
Title:  Clinical and experimental hypertension (New York, N.Y. : 1993)     Volume:  -     ISSN:  1525-6006     ISO Abbreviation:  Clin. Exp. Hypertens.     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-3-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9305929     Medline TA:  Clin Exp Hypertens     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Nephrology, Saitama Medical University , Iruma , Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Nonamethylcyclopentyl Cation Rearrangement Mysteries Solved.
Next Document:  Mitochondrial Hormesis Links Low-Dose Arsenite Exposure to Lifespan Extension.